According to latest report published by MarketsandMarkets, the report "Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Home Care) & Test Type - Global Forecast to 2027", is projected to reach USD 5.7 billion by 2027 from USD 3.9 billion in 2022, at a CAGR of 8.1%.
Browse 198 market data Tables and 44 Figures spread through 237 Pages and in-depth TOC on "Urinalysis Market - Global Forecast to 2027"
View detailed Table of Content here -https://www.marketsandmarkets.com/Market-Reports/urinalysis-systems-market-153479294.html
Development of new diagnostic products and, government support boosting the market. Emerging economies such as India and Japan are providing lucrative opportunities for the players operating in the urinalysis market.
The consumables segment accounted for the largest share of the urinalysis market, by product segment, in 2021
Based on product, the urinalysis market is segmented into consumables and instruments. The consumables segment accounted for the largest share of the urinalysis market, mainly due to the growth of POC diagnostics products market, advancing diagnosis technologies with efficient and rapid results and increased emerging opportunities.
The pregnancy & fertility tests segment accounted for the largest share of the urinalysis market, by test type segment, in 2021
Based on test type, the urinalysis market is segmented into pregnancy & fertility tests, biochemical tests and sediment urinalysis. The pregnancy & fertility tests segment accounted for the largest share of the urinalysis market, mainly due to the growth of public awareness about early pregnancy detection and increased R&D investments in healthcare.
The diseases screening segment accounted for the largest share of the urinalysis market, by application segment, in 2021
Based on application, the urinalysis market is segmented into disease screening and pregnancy & fertility tests. The disease screening segment accounted for the largest share of the urinalysis market, mainly due to the technological advancements in urine analyzers, increased focus on preventive care and increased funding for diagnostic research.
Diagnostic laboratories segment to register the highest growth rate during the forecast period
The urinalysis market is segmented into diagnostic laboratories, hospitals & clinics, home care settings and research laboratories and institutes based on end user. In 2021, the diagnostic laboratories segment accounted for the largest share of the urinalysis market. The large share of this segment can mainly be attributed to the increased investment in the biotech and pharmaceutical industry, increased R&D in the POC diagnostic segment.
North America is the largest regional market for urinalysis market
The global urinalysis market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest regional market for urinalysis market in 2021. The large share of North America in this market can be attributed to the government's support for research in the region, increased government funsing for the development of preventive care diagnostics.
The major players operating in urinalysis market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), Abbott Laboratories (US), Danaher Corporation (US), Sysmex Corporation (Japan), Thermo Fisher Scientific, Inc. (US), Quidel Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US) and EKF Diagnostics (UK).
Don’t miss out on business opportunities in Urinalysis Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441